SENIOR LEADERSHIP

高层领导

• 批准号: 8636563
• 负责人: JOSEPH Rocco BERTINO
• 金额: --
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-03-13 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8636563
• 关键词: Appointment; Basic Science; Cancer Center Support Grant; Cancer Institute of New Jersey; Clinical; Clinical Sciences; Comprehensive Cancer Center; Health Sciences; Human; Individual; Institutes; Instruction; Laboratories; Leadership; Medical Oncology; Mentorship; Mission; National Cancer Institute; New Brunswick; Population Sciences; Positioning Attribute; Prevention; Prostate; Public Health; Research; Resource Sharing; Services; Translational Research; Wages; programs

PROJECT SUMMARY (See instructions): Although senior leadership has been re-organized, the actual consistency and interactivity of the team remains stable. In fact, Dr. DiPaola was appointed as Director of CINJ following multiple appointments at CINJ including Co-Leader of the Prostate Program, Chief of Medical Oncology and Associate Director for Clinical Science. Dr. Edmund Lattime, a prior Associate Director, was appointed to the position of Deputy Director in 2008 by Dr. DiPaola. Dr. Joseph R. Bertino remains as Chief Scientific Officer. Dr. Michael Reiss continues as Associate Director for Translational Science and has appropriately assumed oversight of all basic science and translational shared resources. Dr. Eileen White, a Program Leader since 2004, was appointed Associate Director for Basic Science and, following a move of her laboratories to the main CINJ building in New Brunswick, increased basic science mentorship at CINJ. Dr. Joseph Aisner is Associate Director for Clinical Science as in the 2004 review, and Dr. Susan Goodin has been appointed Assistant Director for Clinical Science and Director ofthe Office of Human Research Services. Stability in administration also remains, as Ms. Linda Barker continues as Associate Director for Administration and Planning. As a new leader. Dr. Helmut Zarbl was appointed Associate Director for Public Health Science, overseeing CINJ's efforts in prevention, control, and population science. Salary support for these individuals is requested only for the effort attributable to research-related activities

项目摘要（参见说明）： 尽管高层领导层进行了重组，但团队实际的一致性和互动性仍然保持稳定。事实上，DiPaola 博士在 CINJ 多次任命后被任命为 CINJ 主任，其中包括前列腺项目联合负责人、肿瘤内科主任和临床科学副主任。前任副主任 Edmund Lattime 博士于 2008 年被 DiPaola 博士任命为副主任。 Joseph R. Bertino 博士仍担任首席科学官。 Michael Reiss 博士继续担任转化科学副主任，并适当承担对所有基础科学和转化共享资源的监督。 Eileen White 博士自 2004 年起担任项目负责人，被任命为基础科学副主任，在将她的实验室搬到新不伦瑞克省的 CINJ 主楼后，增加了 CINJ 的基础科学指导。 根据 2004 年的审查，约瑟夫·艾斯纳 (Joseph Aisner) 博士担任临床科学副主任，苏珊·古丁 (Susan Goodin) 博士被任命为临床科学助理主任和人类研究服务办公室主任。琳达·巴克 (Linda Barker) 女士继续担任行政和规划副主任，行政管理也保持稳定。作为新领导。 Helmut Zarbl 博士被任命为公共卫生科学副主任，负责监督 CINJ 在预防、控制和人口科学方面的工作。 仅针对与研究相关的活动所付出的努力才要求为这些人提供工资支持